LDLR and metabolic syndrome: In parallel, loss of Sirt3 was associated with accelerated weight gain and elevated plasma glucose in LDLR−/− mice in the current study; however, without affecting serum lipid levels or glucose tolerance, thus not fulfilling the criteria for a full-grown metabolic syndrome [2].